Stock Analysis, Dividends, Split History

APEN / Apollo Endosurgery Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price6.19
Volume5,500.00
Market Cap ($M)107.03
Enterprise Value ($M)106.69
Book Value ($M)56.84
Book Value / Share3.29
Price / Book1.90
NCAV ($M)3.64
NCAV / Share0.21
Price / NCAV29.70
Share Statistics
Common Shares Outstanding 10,695,711
Preferred Stock Shares Outstanding 0
Common Stock Shares Outstanding 10,688,992
Scoring Models
Piotroski F-Score4.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-0.50
Return on Assets (ROA)-3.55
Return on Equity (ROE)-3.91
Balance Sheet (mrq) ($M)
Assets114.00
Liabilities57.16
Quick Ratio2.00
Current Ratio2.53
Income Statement (mra) ($M)
Revenues64,868,000.00
Operating Income-20.76
Net Income-41.17
Earnings Per Share Basic And Diluted-105.69
Cash Flow Statement (mra) ($M)
Cash From Operations-12.90
Cash from Investing-2.17
Cash from Financing-2.17
Identifiers and Descriptors
CUSIP548910306
Central Index Key (CIK)1251769

Split History

Stock splits are used by Apollo Endosurgery Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related News Stories

Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q2 2018 Results - Earnings Call Transcript

2018-08-12 seekingalpha
Apollo Endosurgery, Inc. (NASDAQ:APEN) Q2 2018 Results Earnings Conference Call August 8, 2018 4:30 PM ET

Apollo Endosurgery Makes Good Progress

2018-06-26 seekingalpha
The company's endo-bariatric products are flying off the shelves even if this comes at the cost of lower gross margins. Demand is set to continue at this brisk pace. (0-2)

FDA says received reports of 5 more deaths from intragastric balloons

2018-06-04 reuters
June 4 (Reuters) - The U.S. Food and Drug Administration on Monday notified healthcare providers that it had received reports of five more deaths in patients using liquid-filled intragastric balloon systems to treat obesity.

CUSIP: 548910306